Processa Pharmaceuticals, Inc. (PCSA)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-243.2%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0 | $0 | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — | — | $5.0K |
| Operating Income | -$13.99M | -$12.05M | -$11.46M | -$27.53M | -$12.13M | -$15.14M | -$3.94M | -$4.52M | -$1.80M | -$1.92M |
| Net Income | -$13.56M | -$11.85M | -$11.12M | -$27.42M | -$11.43M | -$14.41M | -$3.36M | -$3.77M | -$1.86M | -$1.92M |
| EPS (Diluted) | $-10.36 | $-96.78 | $-8.48 | $-34.05 | $-0.75 | — | — | — | $-0.06 | $-0.07 |
| Total Assets | $7.81M | $3.23M | $5.79M | $8.62M | $26.46M | $25.21M | $10.88M | $12.48M | $2.98M | $2.36M |
| Total Liabilities | $2.24M | $1.53M | $797.5K | $1.15M | $978.4K | $2.27M | $2.87M | $2.78M | $2.61M | $97.7K |
| Shareholders' Equity | $5.58M | $1.70M | $4.99M | $7.47M | $25.49M | $22.94M | $8.01M | $9.70M | $373.2K | -$2.27M |
| Cash & Equivalents | $5.54M | $1.19M | $4.71M | $6.50M | $16.50M | $15.42M | $691.5K | $1.74M | $2.85M | $1.07M |
| Operating Cash Flow | -$11.39M | -$11.25M | -$8.06M | -$9.61M | -$8.72M | -$3.14M | -$2.75M | -$3.71M | -$1.65M | -$2.16M |
| Capital Expenditures | — | $3.2K | $2.8K | — | — | — | — | — | $20.6K | $23.8K |
| Shares Outstanding | 2.57M | 148.1K | 1.29M | 801.8K | 15.71M | 14.18M | 5.49M | 5.53M | 35.27M | 31.75M |